Calcium Dobesilate + Lignocaine + Hydrocortisone + Zinc Oxide Cream in PCD pharma franchise in Hyderabad

Calcium Dobesilate + Lignocaine + Hydrocortisone + Zinc Oxide Cream in pharmaceutical manufacturing company in Mumbai

Calcium Dobesilate + Lignocaine + Hydrocortisone + Zinc Oxide Cream in anorectal care pharma franchise in Pune

Calcium Dobesilate + Lignocaine + Hydrocortisone + Zinc Oxide Cream in pharma suppliers in Delhi

Calcium Dobesilate + Lignocaine + Hydrocortisone + Zinc Oxide Cream in pharma export companies in Kolkata
Calcium Dobesilate + Lignocaine + Hydrocortisone + Zinc Oxide Cream in pharma franchise opportunities in Bengaluru

Dapa V 10-100 SR Tablet

Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Please Contact For Best Price

Dapa V 10/100 SR Tablet is a dual oral antidiabetic formulation combining the SGLT2 inhibitor Dapagliflozin with the DPP-4 inhibitor Vildagliptin. This combination provides synergistic glycemic control by enhancing insulin secretion and reducing renal glucose reabsorption, leading to increased urinary glucose excretion. It not only improves blood sugar control but also aids in weight management and cardiovascular protection in patients with type 2 diabetes mellitus. The sustained-release formulation ensures prolonged therapeutic action and improved patient adherence.

Read More

About the Product

Dapa V 10/100 SR Tablet is a dual oral antidiabetic formulation combining the SGLT2 inhibitor Dapagliflozin with the DPP-4 inhibitor Vildagliptin. This combination provides synergistic glycemic control by enhancing insulin secretion and reducing renal glucose reabsorption, leading to increased urinary glucose excretion. It not only improves blood sugar control but also aids in weight management and cardiovascular protection in patients with type 2 diabetes mellitus. The sustained-release formulation ensures prolonged therapeutic action and improved patient adherence.

Common side effects may include urinary tract infections, genital infections, nausea, diarrhea, abdominal discomfort, and increased urination. Rarely, hypoglycemia may occur, especially when combined with other antidiabetic drugs.

Indicated for patients with Type 2 Diabetes Mellitus when diet, exercise, and Metformin monotherapy do not provide adequate glycemic control. Also suitable as part of combination therapy for better blood sugar management.

Not recommended for patients with Type 1 diabetes or diabetic ketoacidosis. Caution is advised in patients with renal impairment. Adequate hydration should be maintained to reduce the risk of dehydration.

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch